Prostatis Group LLC Acquires New Holdings in CME Group Inc. (NASDAQ:CME)
MarketBeat
Prostatis Group LLC bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,469 shares of the financial services provider's stock, valued at approximately $341,000.
NASDAQ:CME